• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/21

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

21 Cards in this Set

  • Front
  • Back
Quinidine
type Ia

MOA : Na+ channel blocker ; slows the upstroke of the action potential and conduction; prolongs the QRS duration of the ECG; intermediate kinetics; also block K+ channels to some extent

Adverse Effects: cardiac = excessive QT prolongation and torsade de pointes; syncope; anticholinergic effects: extracardiac effects = GI (up to 50% of pts); CNS effects at toxic levels; idiosyncratic reactions
Procainamide
type Ia

MOA: Na+ channel blocker; similar to quinidine in terms of electrophysiologic effects;

PKs: hepatically metabolized with active metabolites (NAPA which has type III activity– eliminated via kidneys…watch renal failure)

Adverse Effects: cardiac = hypotension (esp IV); arrhythmia; extracardiac = LUPUS LIKE SYNDROME (1/3 of pts on long-term therapy) – arthralgias and arthritis, maybe pleuritis, pericarditis, pulmonary dz; GI; agranulocytosis
Disopyramide (Norpace)
type Ia

MOA: Na+ channel blocker; cardiac effects are similar to quinidine; marked cardiac antimuscarinic (anticholinergic: ) effects = many side effects;

Adverse Effects: cardiac = arrhythmias; heart failure; extracardiac = anticholinergic (see above); GI
Lidocaine (Xylocaine)
type Ib

MOA: Na+ channel blocker;

Adverse Effects: cardiac = arrhythmias; hypotension; extracardiac = neurologic (dose-related)…paresthesias, tremor, N (chemoreceptor trigger zone), lightheadedness, convulsions, slurred speech, hearing problems
Mexiletine (Mexitil)
type Ib

MOA: Na+ channel blocker

Adverse Effects: frequent at therapeutic doses = neurologic…tremor, blurred vision, lethargy; GI
tocainide (Tonocard)
type Ib

MOA: Na+ channel blocker

Adverse Effects: frequent at therapeutic doses = neurologic…tremor, blurred vision, lethargy; GI
Flecainide (Tambocor)
type Ic

MOA: blocks Na+ and K+ channels w/ slow unblocking kinetics

CAST – flecainide used = 2x mortality rate in pts taking flecainide and encainide…
Propafenone (Rythmol)
type Ic

MOA: weak beta blocker; similar to quinidine

Adverse Effects: metallic taste, constipation, arrhythmia
Moricizine (Ethmozine)
type Ic

MOA: potent Na+ channel blocker

Adverse Effects: arrhythmias, dizziness, N
β- blockers
β- blockers - type II

MOA: block cardiac beta receptors

Adverse Effects: cardiac = CHF; extracardiac = watch asthma and COPD pts!!! ↓IOP; CNS…sedation, depression, sleep disturbances; impotence
acebutolol (Sectral)
β- blockers - type II

MOA: block cardiac beta receptors

Adverse Effects: cardiac = CHF; extracardiac = watch asthma and COPD pts!!! ↓IOP; CNS…sedation, depression, sleep disturbances; impotence
esmolol (Brevibloc)
β- blockers - type II

MOA: block cardiac beta receptors

Adverse Effects: cardiac = CHF; extracardiac = watch asthma and COPD pts!!! ↓IOP; CNS…sedation, depression, sleep disturbances; impotence
β- blockers - type II
propranolol (Inderal)
β- blockers - type II

MOA: block cardiac beta receptors

Adverse Effects: cardiac = CHF; extracardiac = watch asthma and COPD pts!!! ↓IOP; CNS…sedation, depression, sleep disturbances; impotence
sotalol (Betapace)
β- blockers - type II

MOA: block cardiac beta receptors

Adverse Effects: cardiac = CHF; extracardiac = watch asthma and COPD pts!!! ↓IOP; CNS…sedation, depression, sleep disturbances; impotence
Amiodarone (Cordarone)
type III; MAJOR AGENT USED!

MOA: K+ channel blocker = prolongation of action potential; also blocks Na+ channels; weak adrenergic and Ca2+ blocking channel capabilities; effective in atrial and ventricular arrhythmias

PKs: poor GI absorption; IV available also (2-3 days to SS level)
• t1/2 = 56 days…takes a few weeks (minimally) to reach some type of steady blood level
• 96% protein bound
• Hepatically metabolized with active metabolites
• Requires blood level monitoring
• Watch drug interactions due to CYP450 enzymes in liver

Adverse Effects: cardiac = bradycardia, heart block; extracardiac = major limitation – but as long as the pt is appropriately monitored…LFTs, PFTs, TFTs, ocular exam
• due to accumulation in many tissues (lung, liver, skin, tears)
• pulmonary toxicity – dose related; see fibrosis (1% fatal)
• abnormal LFTs and hepatitis
• gray-blue skin discoloration in sun exposed areas and photosensitivity in general
• corneal microdeposits – may see halos in peripheral vision…microdeposits seen in almost all pts
• optic neuritis – rare = blindness
• blocks conversion of T4 to T3= hypo or hyperthyroidism

Widely use
Bretylium
type III

MOA: K+ channel blocker = prolongation of action potential; also blocks Na+ channels; weak adrenergic and Ca2+ blocking channel capabilities; effective in atrial and ventricular arrhythmias

Adverse Effects: arrhythmia; dissimilar to amiodarone in terms of the extracardiac effects
dofetilide (Tikosyn)
type III

MOA: K+ channel blocker = prolongation of action potential; also blocks Na+ channels; weak adrenergic and Ca2+ blocking channel capabilities; effective in atrial and ventricular arrhythmias

Adverse Effects: arrhythmia; dissimilar to amiodarone in terms of the extracardiac effects
ibutilide (Corvert)
type III

MOA: K+ channel blocker = prolongation of action potential; also blocks Na+ channels; weak adrenergic and Ca2+ blocking channel capabilities; effective in atrial and ventricular arrhythmias

Adverse Effects: arrhythmia; dissimilar to amiodarone in terms of the extracardiac effects
sotalol (Betapace)
type III

MOA: K+ channel blocker = prolongation of action potential; also blocks Na+ channels; weak adrenergic and Ca2+ blocking channel capabilities; effective in atrial and ventricular arrhythmias

Adverse Effects: arrhythmia; dissimilar to amiodarone in terms of the extracardiac effects
diltiazem (Cardizem)
type IV

MOA: slowing of inward Ca2+ through L-channels

Adverse Effects: cardiac = verapamil has dose-related cardiotoxic effects; both arrhythmia; extracardiac = verapamil causes constipation, diltiazem causes diarrhea; peripheral edema, nervousness
Verapamil (Calan
type IV

MOA: slowing of inward Ca2+ through L-channels

Adverse Effects: cardiac = verapamil has dose-related cardiotoxic effects; both arrhythmia; extracardiac = verapamil causes constipation, diltiazem causes diarrhea; peripheral edema, nervousness